戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 xpression of CD16, and the ability to reduce nitroblue tetrazoleum dye was inhibited in transfectants
2 ease (CGD), which is diagnosed by use of the nitroblue tetrazolium (NBT) and Fc-Oxyburst assays that
3 were detected spectrophotometrically using a nitroblue tetrazolium (NBT) assay in cells treated with
4 timulated isoniazid oxidation as measured by nitroblue tetrazolium (NBT) reduction and O2 consumption
5   Cell differentiation was determined by the nitroblue tetrazolium (NBT) reduction assay.
6       Superoxide dismutase (SOD) inhibitable nitroblue tetrazolium (NBT) reduction was determined as
7                   Protein blots stained with nitroblue tetrazolium (NBT) showed intensive protein-pol
8 tion and immunocompetence measured using the Nitroblue Tetrazolium (NBT) test were significantly diff
9 , superoxide production, as monitored by the nitroblue tetrazolium (NBT) test, was detected in up to
10 ion as measured by (1) the ability to reduce nitroblue tetrazolium (NBT), (2) the expression of Mac-I
11 press CD11b and 75% of these cells to reduce nitroblue tetrazolium (NBT).
12 cceptors for NADH oxidoreductase (0.3 mmol/L nitroblue tetrazolium and 0.1 mmol/L ferricyanide) inhib
13 preparation: the Cyt c assay to cytosol, the nitroblue tetrazolium assay to plasma membrane, and the
14                                              Nitroblue tetrazolium dye reduction assays of colonies o
15 , HO2( *)) were detected by the reduction of nitroblue tetrazolium into formazan, and hydroxyl radica
16 in acquired the equivalent ability to reduce nitroblue tetrazolium or cytochrome C.
17 4 subclones MR-2 and R4 cells as measured by nitroblue tetrazolium reduction and tRA-inducible genes
18 OD and tcvSOD recombinant proteins inhibited nitroblue tetrazolium reduction of superoxide anion gene
19 entiation, as measured by growth inhibition, nitroblue tetrazolium reduction, nuclear body relocaliza
20 RA-differentiation inducer, as determined by nitroblue tetrazolium reduction.
21  hexose-monophosphate shunt activation using nitroblue tetrazolium reduction.
22 denced by morphology, immunophenotyping, and nitroblue tetrazolium reduction.
23  in anthers and embryo sacs, as evidenced by nitroblue tetrazolium staining.
24 t risk; AN/AR) was estimated with the use of nitroblue tetrazolium staining.
25 eutrophil function in the proband, including nitroblue tetrazolium tests, myeloperoxidase assays, neu
26 imitation, an activity staining method using nitroblue tetrazolium was developed.
27 d methods for detection of superoxide (e.g., nitroblue tetrazolium).
28 ine dinucleotide hydrogen; substrate, 184 uM Nitroblue tetrazolium, and 1.9 uM phenazine methosulfate
29 hrome c (Cyt c), assays for the reduction of nitroblue tetrazolium, and assays for the chemiluminesce
30 on of NADH on nitroprusside was inhibited by nitroblue tetrazolium, ferricyanide, and diphenyliodoniu
31  NO release was inhibited by the presence of nitroblue tetrazolium, ferricyanide, and diphenyliodoniu
32                   First, in experiments with nitroblue tetrazolium, we found that 25% of parasitophor
33 ADPH-dependent reduction of cytochrome c and nitroblue tetrazolium.
34 ll surface antigens, as well as reduction of nitroblue tetrazolium.
35 so inhibited the NADH-dependent reduction of nitroblue tetrazolium.
36 nectary tissues, nectaries were stained with nitroblue tetrazolium.